News & Updates
Filter by Specialty:
New long-term data confirm safety, efficacy of atogepant for migraine prevention
27 Apr 2024
byJairia Dela Cruz
Daily use of the oral calcitonin gene-related peptide (CGRP) receptor antagonist atogepant to prevent migraine is associated with a favourable safety profile and sustained improvements in efficacy outcomes, according to the 52-week data from an ongoing, open-label, 156-week safety extension study.
New long-term data confirm safety, efficacy of atogepant for migraine prevention
27 Apr 2024Vertical COVID-19 transmission low in SG
26 Apr 2024
byAudrey Abella
Transmission of SARS-CoV-2 infection from mothers to newborns appears to be rare in a cohort study conducted by the KK Women’s and Children’s Hospital (KKH), Singapore General Hospital (SGH), and National University Hospital (NUH).